Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.
Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a Locations section with Oklahoma as a trial site. This updates where the study is recruiting and participating locations are shown.SummaryDifference0.2%
- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.2.0 version.SummaryDifference0.1%
- Check52 days agoChange DetectedThe generic government funding/operating status notice was removed from the page, while the study details remain unchanged.SummaryDifference0.4%
- Check67 days agoChange DetectedNo additions or deletions to the page's core content are evident; the study's title, conditions, design, and locations appear unchanged. Any observed differences are likely minor formatting or layout adjustments rather than substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check95 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check103 days agoChange DetectedUpdate: version from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.1%
Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.